370 related articles for article (PubMed ID: 23008334)
1. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.
Hirschhorn-Cymerman D; Budhu S; Kitano S; Liu C; Zhao F; Zhong H; Lesokhin AM; Avogadri-Connors F; Yuan J; Li Y; Houghton AN; Merghoub T; Wolchok JD
J Exp Med; 2012 Oct; 209(11):2113-26. PubMed ID: 23008334
[TBL] [Abstract][Full Text] [Related]
2. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.
Qui HZ; Hagymasi AT; Bandyopadhyay S; St Rose MC; Ramanarasimhaiah R; Ménoret A; Mittler RS; Gordon SM; Reiner SL; Vella AT; Adler AJ
J Immunol; 2011 Oct; 187(7):3555-64. PubMed ID: 21880986
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.
Church SE; Jensen SM; Antony PA; Restifo NP; Fox BA
Eur J Immunol; 2014 Jan; 44(1):69-79. PubMed ID: 24114780
[TBL] [Abstract][Full Text] [Related]
4. Role of T-bet, the master regulator of Th1 cells, in the cytotoxicity of murine CD4
Eshima K; Misawa K; Ohashi C; Iwabuchi K
Microbiol Immunol; 2018 May; 62(5):348-356. PubMed ID: 29577371
[TBL] [Abstract][Full Text] [Related]
5. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
[TBL] [Abstract][Full Text] [Related]
6. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.
Kjaergaard J; Peng L; Cohen PA; Drazba JA; Weinberg AD; Shu S
J Immunol; 2001 Dec; 167(11):6669-77. PubMed ID: 11714839
[TBL] [Abstract][Full Text] [Related]
7. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
[TBL] [Abstract][Full Text] [Related]
8. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.
Redmond WL; Linch SN; Kasiewicz MJ
Cancer Immunol Res; 2014 Feb; 2(2):142-53. PubMed ID: 24778278
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.
Jensen SM; Twitty CG; Maston LD; Antony PA; Lim M; Hu HM; Petrausch U; Restifo NP; Fox BA
J Immunol; 2012 Jul; 189(2):767-76. PubMed ID: 22723522
[TBL] [Abstract][Full Text] [Related]
11. OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors.
Kim MY; Bekiaris V; McConnell FM; Gaspal FM; Raykundalia C; Lane PJ
J Immunol; 2005 Feb; 174(3):1433-7. PubMed ID: 15661901
[TBL] [Abstract][Full Text] [Related]
12. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
14. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4
He K; Liu P; Xu LX
Cell Death Dis; 2017 Mar; 8(3):e2703. PubMed ID: 28333145
[TBL] [Abstract][Full Text] [Related]
15. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S
J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093
[TBL] [Abstract][Full Text] [Related]
16. Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain.
Krymskaya L; Lee WH; Zhong L; Liu CP
J Immunol; 2005 Feb; 174(3):1188-95. PubMed ID: 15661872
[TBL] [Abstract][Full Text] [Related]
17. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
18. Requirements for the differentiation of innate T-bet
Kawabe T; Yi J; Kawajiri A; Hilligan K; Fang D; Ishii N; Yamane H; Zhu J; Jankovic D; Kim KS; Trinchieri G; Sher A
Nat Commun; 2020 Jul; 11(1):3366. PubMed ID: 32632165
[TBL] [Abstract][Full Text] [Related]
19. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT
J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]